Clinical Trials Browser

Breast Neoplasms

NCT03671330 2025-10-31

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

Phase 2 Completed

327 enrolled

Breast

Breast Neoplasms

NCT03822468 2025-10-16

AMALEE

Phase 2 Completed

376 enrolled 17 charts

Breast

Breast Neoplasms

NCT05549505 2025-08-29

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Phase 2 Completed

152 enrolled 16 charts

Breast

Breast Neoplasms

NCT03909152 2025-07-28

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Phase 2 Completed

34 enrolled 9 charts

Gynecologic

Granulosa Cell Ovarian Cancer

NCT02040857 2025-04-29

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

Phase 2 Completed

162 enrolled 12 charts

Breast

Breast Neoplasms

NCT03219476 2025-04-29

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Phase 2 Completed

37 enrolled 10 charts

Breast

Breast Neoplasms

NCT03691493 2025-02-17

ASPIRE

Phase 2 Completed

36 enrolled 17 charts

Breast

Breast Neoplasms

NCT04294225 2025-01-28

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Phase 2 Completed

161 enrolled 12 charts

Breast

Breast Neoplasms

NCT03839823 2024-10-09

RIGHT Choice

Phase 2 Completed

222 enrolled 17 charts

Breast

Breast Neoplasms

NCT02188745 2024-07-17

POLLY

Phase 2 Completed

19 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03272477 2024-04-17

TP-II

Phase 2 Completed

257 enrolled

Breast

Breast Neoplasms

NCT02648477 2024-03-19

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

Phase 2 Completed

30 enrolled 11 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03321981 2024-03-07

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

Phase 2 Completed

105 enrolled 23 charts

Lethal Congenital Contracture Syndrome 2

NCT03555877 2023-07-07

AMICA

Phase 2 Completed

56 enrolled

Breast

Breast Cancer Metastatic

NCT00921115 2023-05-19

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

Phase 2 Completed

42 enrolled 5 charts

Breast

Breast Neoplasms

NCT02894398 2023-03-13

INGE-B

Phase 2 Completed

388 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00128843 2023-03-06

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

Phase 2 Completed

103 enrolled

Breast

Breast Neoplasms

NCT04436744 2023-02-02

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

Phase 2 Completed

221 enrolled 21 charts

Breast

Breast Neoplasms

NCT02440230 2022-12-30

SEAT

Phase 2 Completed

110 enrolled

Breast

Breast Neoplasms

NCT01989780 2022-08-04

BOOSTER

Phase 2 Completed

160 enrolled

Breast

Breast Neoplasms

NCT00405938 2021-11-18

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

Phase 2 Completed

79 enrolled 7 charts

Breast

Breast Neoplasms

NCT00629616 2021-06-09

NIMFEA

Phase 2 Completed

116 enrolled

Breast

Breast Neoplasms

NCT00256217 2021-05-11

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Phase 2 Completed

42 enrolled 10 charts

Breast

Carcinoma, Intraductal, Noninfiltrating

NCT00871858 2021-02-24

HORGEN

Phase 2 Completed

120 enrolled 11 charts

Breast

Breast Neoplasms

NCT00570323 2020-07-28

PACT001

Phase 2 Completed

72 enrolled 8 charts

Breast

Breast Neoplasms

NCT02441946 2020-06-17

neoMONARCH

Phase 2 Completed

224 enrolled 20 charts

Breast

Breast Neoplasms

NCT02291913 2020-02-17

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Phase 2 Completed

48 enrolled 13 charts

Breast

Breast Neoplasms

NCT00186121 2019-10-07

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

Phase 2 Completed

35 enrolled 11 charts

Breast

Breast Neoplasms

NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Phase 2 Completed

40 enrolled 13 charts

EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT00728949 2018-06-06

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Phase 2 Completed

93 enrolled 14 charts

Breast

Breast Neoplasms

NCT02549430 2017-08-01

TREnd

Phase 2 Completed

115 enrolled

Breast

Breast Neoplasms

NCT01972984 2016-02-04

NEO ER 11-05

Phase 2 Completed

20 enrolled

Breast

Breast Neoplasms

NCT00081510 2015-04-15

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)

Phase 2 Completed

110 enrolled

Breast

Breast Neoplasms

NCT00077025 2014-07-16

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Phase 2 Completed

174 enrolled

Breast

Breast Neoplasms

NCT00057941 2014-05-12

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

Phase 2 Completed

148 enrolled 7 charts

Breast

Breast Neoplasms

NCT00066378 2013-10-24

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

Phase 2 Completed

71 enrolled

Breast

Breast Neoplasms

NCT00354640 2013-06-24

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Phase 2 Completed

11 enrolled 5 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00004900 2013-05-30

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms

NCT00004906 2013-05-30

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms

NCT00005908 2013-03-19

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

Phase 2 Completed

30 enrolled 12 charts

Breast

Breast Neoplasms

NCT00244959 2013-03-19

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

Phase 2 Completed

54 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00049062 2013-02-21

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms

NCT00181688 2012-12-05

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

Phase 2 Completed

35 enrolled

Gynecologic

Ovarian Neoplasms

NCT00259090 2012-08-16

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Phase 2 Completed

120 enrolled 10 charts

Breast

Breast Neoplasms

NCT00235937 2011-01-21

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

Phase 2 Completed

45 enrolled

Breast

Breast Neoplasms

NCT00357110 2010-12-21

@FAME

Phase 2 Completed

13 enrolled 7 charts

Breast

Breast Neoplasms, Neoplasms

NCT00287534 2009-06-09

ARNO-95

Phase 2 Completed

1,059 enrolled

Breast

Breast Neoplasms

NCT00255463 2009-04-23

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

Phase 2 Completed

185 enrolled

Breast

Breast Neoplasms

Clinical Trials

PREcoopERA

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

AMALEE

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

ASPIRE

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

RIGHT Choice

POLLY

TP-II

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

AMICA

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

INGE-B

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

SEAT

BOOSTER

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

NIMFEA

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

HORGEN

PACT001

neoMONARCH

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

TREnd

NEO ER 11-05

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

@FAME

ARNO-95

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study